Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Diluted Average) (2018 - 2024)

Skinvisible (SKVI) has disclosed Shares Outstanding (Diluted Average) for 7 consecutive years, with $5.1 million as the latest value for Q4 2024.

  • Quarterly Shares Outstanding (Diluted Average) rose 11.49% to $5.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.1 million through Dec 2024, up 11.49% year-over-year, with the annual reading at $5.1 million for FY2024, 11.49% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $5.1 million in Q4 2024 for Skinvisible, up from $4.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $5.1 million in Q4 2024 to a low of $4.5 million in Q1 2020.
  • Historically, Shares Outstanding (Diluted Average) has averaged $4.6 million across 5 years, with a median of $4.5 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 55.09% in 2020 and later changed 0.0% in 2021.
  • Year by year, Shares Outstanding (Diluted Average) stood at $4.5 million in 2020, then grew by 1.06% to $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then rose by 11.49% to $5.1 million in 2024.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SKVI at $5.1 million in Q4 2024, $4.5 million in Q3 2024, and $4.6 million in Q2 2024.